Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

126.99
Delayed Data
As of Sep 04
 +0.46 / +0.36%
Today’s Change
90.99
Today|||52-Week Range
143.45
+6.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.4B1.5B1.2B580.4M
 
 
 
 
 
Cost of Goods Sold45.5M241.7M81.9M61.0M
 
 
 
 
 
Depreciation And Amortization35.0M38.2M48.4M63.3M
 
 
 
 
 
 
Operating ExpensesGross Income1.3B1.2B1.1B456.2M
 
 
 
 
 
General Expenses1.1B1.2B1.3B1.1B
 
 
 
 
 
Research And Development707.7M806.2M918.8M855.5M
 
 
 
 
 
Total Operating Expenses1.2B1.5B1.4B1.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income221.7M4.2M-199.4M-641.5M
 
 
 
 
 
Extraordinary Charge-124.7M-1.8M-704.0M-79.9M
 
 
 
 
 
Interest Expense On Debt38.5M16.7M22.7M72.9M
 
 
 
 
 
Other Expenses0.000.00-49.9M59.4M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income60.4M-12.4M-976.1M-734.9M
 
 
 
 
 
Income Taxes-19.3M-38.8M-288.6M-7.0M
 
 
 
 
 
Minority Interest-11.6M-55.9M-242.5M-4.2M
 
 
 
 
 
Discontinued Operations0.000.000.00-912.0K
 
 
Net Income29.6M-107.0M-445.0M-738.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS204.9M211.9M224.9M235.3M
 
 
 
 
 
Shares To Calculate EPS Diluted208.8M211.9M224.9M235.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.14-$0.50-$1.98-$3.14
 
 
 
 
 
EPS Diluted$0.14-$0.50-$1.98-$3.14